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Abstract
Background: Poxviruses engage in a complex and intricate dialogue with host cells as part of their strategy for replication.
However, relatively little molecular detail is available with which to understand the mechanisms behind this dialogue.
Methodology/Principal Findings: We designed a specialized microarray that contains probes specific to all predicted ORFs
in the Monkeypox Zaire (MPXV) and Vaccinia Western Reserve (VACV) genomes, as well as .18,000 human genes, and used
this tool to characterize MPXV and VACV gene expression responses in vitro during the course of primary infection of human
monocytes, primary human fibroblasts and HeLa cells. The two viral transcriptomes show distinct features of temporal
regulation and species-specific gene expression, and provide an early foundation for understanding global gene expression
responses during poxvirus infection.
Conclusions/Significance: The results provide a temporal map of the transcriptome of each virus during infection, enabling
us to compare viral gene expression across species, and classify expression patterns of previously uncharacterized ORFs.
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Introduction
The family Poxviridae consists of large double-stranded DNA
viruses, which replicate exclusively in the cytoplasm of cells.
Members of the orthopox genus include variola, the causative agent
of human smallpox, monkeypox (MPXV) and vaccinia (VACV).
Monkeypox (MPXV) infection causes severe disease in both
humans and non-human primates, and is an emerging infectious
disease, with cases observed in Africa [1–4], and recently, in the
United States [5,6].
The genomes of several MPXV strains have been sequenced
[7–10], however virtually no modern molecular biology has been
applied to the study of live MPXV virus. Much can be inferred
about the life cycle, gene transcription, and putative host immune
counter-defenses from the genome sequence of MPXV, and
comparison to related poxviruses [7,8]. However, none of these
inferred features have been tested directly in vitro with MPXV
virus. Moreover, the terminal ends of the genome, which encode
immune-modulating and virulence genes, are the regions of the
genome that vary the most between MPXV and VACV [8].
The mechanisms of VACV transcription are well described
[11]. Vaccinia virus transcription proceeds in three phases. During
the first, early transcriptional phase, factors are expressed that are
involved in viral DNA synthesis, intermediate gene expression,
and modulation of the host anti-viral response [11]. It is believed
that approximately half of the vaccinia virus genome is transcribed
during this phase, before DNA replication [12,13]. The class of
genes expressed during the second or intermediate phase,
immediately after DNA replication, is a much smaller group
[14,15], mainly trans activating factors for late gene transcription.
The third or late class of VACV genes encodes structural
components of the virus, as well as components of the early
PLoS ONE | www.plosone.org 1 July 2008 | Volume 3 | Issue 7 | e2628transcriptional apparatus so that they can be synthesized and
packaged for the next round of infection [11].
We examined the temporal features of in vitro infection with
monkeypox and vaccinia in several different human cell types, and
in this study, focused on patterns of viral gene expression. For this
purpose, we developed a combination poxvirus-human DNA
microarray. DNA microarray profiling has been applied success-
fully to the study of herpesvirus genomes (a similarly complex
DNA virus) using both short [16] and long oligonucleotide arrays
[17–19]. Our results provide a complete transcriptional map of the
vaccinia and monkeypox genomes and clarify long-standing
assumptions about the poxvirus life cycle in host cells.
Results
In order to understand the dynamics of viral gene expression on a
global scale, we performed high-resolution timecourse experiments
with vaccinia (VACV) and monkeypox (MPXV) viruses. We infected
primary human monocytes, primary human fibroblasts, and HeLa
cells with Vaccinia WR or Monkeypox Zaire at a high multiplicity of
infection (in order to maximize the proportion of infected cells and
synchronize the infection), and mapped the transcriptional response
of these viruses during one round of the infection cycle.
Design and validation of a poxvirus-human DNA
microarray
Because our overall goal was to monitor both viral and host
gene expression simultaneously during the course of infection, we
developed and tested a specialized poxvirus-human DNA micro-
array. Using the monkeypox [7,8] and vaccinia [20] genomes, and
software developed in our lab [21], we designed primers for all 190
predicted open reading frames (ORFs) in the MPXV-ZAI genome
with an overall PCR success rate of 94.7% (180/190 ORFs), and
all 217 predicted open reading frames (ORFs) in the vaccinia-WR
genome with an overall PCR success rate of 94.9% (206/217
ORFs). In a preliminary set of experiments, these MPXV and
VACV DNAs were printed on a microarray along with 1152
human cDNAs as controls. Test hybridizations were performed
using control uninfected human K562 cell line RNA and RNA
from fresh human PBMCs infected with MPXV-ZAI (24 hrs post-
infection; MOI=1) (Figure 1A). The MPXV array elements
hybridized specifically to RNA from the infected sample (red
MPXV spots, Figure 1A). Those same spots appeared black (no
hybridization) when RNA from uninfected control cells was used
(Figure 1A). The mean pixel intensity of the MPXV array
elements in the infected sample was 1,333.63, which was
significantly higher than the mean pixel intensity of the
corresponding elements in the uninfected control hybridization
(219.52). In addition, we also tested the full poxvirus-human
microarray using RNA samples from an in vitro infection with
monkeypox. Figure 1B shows results using primary human
monocytes, either uninfected or 48 hrs post infection in the red
channel, with a reference consisting of a mix of poxvirus
transcripts and human transcripts in the green channel. Thus,
the poxvirus-human arrays were able to capture nearly all
poxvirus transcripts with little background hybridization from
Figure 1. Validation of poxvirus-human microarray. (A) Monkeypox ORF PCR products were tested by printing the 384-well plate of
monkeypox products on an array with three 384-well plates of human gene clones. Each spot from one well of a 384-well plate was printed 8 times
(across, in rows). Two of the three 384-well plates of human clones were printed, then the monkeypox plate was printed (monkeypox spots start at
the fifth row down, seventeenth spot from the left), and then the third 384-well plate of human clones was printed. Test hybridizations were
performed using control uninfected cell line RNA from K562 cells (Uninfected Control RNA) or RNA from human PBMCs infected with monkeypox at
an MOI of 1 at 24 hours post infection (Monkeypox RNA) labeled with Cy 5 versus common reference RNA (Stratagene, Inc.) labeled with Cy3. (B) 384-
well plates of the ORF Monkeypox ORF PCR products were spotted in duplicate on the human array (bottom of the sector, Poxvirus spots). One of the
48 sectors is shown. Test hybridizations were performed with Cy5-labeled RNA from uninfected primary human monocytes or Cy5-labeled RNA from
MPXV-infected primary human monocytes at 48 hours post-infection, versus a Cy 3 labeled common reference pool (Universal Human Reference,
Stratagene Inc.) combined with an equal mix of poxvirus transcripts from all timepoints.
doi:10.1371/journal.pone.0002628.g001
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primary cells, we were able to detect transcripts representing
98.16% and 95.58% of poxviral genes (as defined by signal .2.5
fold over background at one of the timepoints) in VACV-WR-
infected fibroblasts and monocytes, respectively, and 99.02% and
98.65% of poxvirus genes in MPXV-ZAI-infected fibroblasts and
monocytes, respectively.
Temporal transcription program of poxviral genes
As a means of exploring global patterns of poxvirus gene
expression, we developed a map of the MPXV and VACV
transcriptomes in human primary monocytes and fibroblasts using
the poxvirus-human arrays and samples taken at 0, 1, 2, 4, 6, 8,
12, and 24 hours post infection. We identified temporal expression
classes of poxvirus genes during infection, including viral
transcripts that were induced early (1–2 hrs post infection), and
transcripts that were induced late in infection (.4 hrs post
infection) (Figs 2 and 3).
171 MPXV and VACV ORFs were expressed early (subset shown
in Figure 2), including genes whose products are known to be
involved in viral DNA replication (DNA polymerase VACVWR065,
viralDNAprocessivityfactorVACVWR141,uracilDNAglycosylase
MPXV E4R), RNA transcription (DNA-dependent RNA polymer-
ase subunits VACVWR112, VACVWR 124, VACVWR 144 and
VACVWR 096 and MPXV G6R, F4L, L4R), and host immune
modulating factors (secreted Il-18 binding protein VACVWR013,
Toll/IL1-recptor suppressor VACVWR172, secreted TNFa binding
protein MPXV J2L, 3-b-hydroxy-d5-steroid dehydrogenase MPXV
A45L, and secreted EGF-like growth factor MPXV D3R).Being that
poxvirus immune modulators are important for pathogenesis and
viral interaction with the host cell environment, we used the poxvirus-
human microarray to determine if, and when the putative MPXV
Figure 2. Early viral gene expression during poxvirus infection. A subset of the complete monkeypox and vaccinia transcriptome
representative of the early transcripts. Timecourses are as follows: Mock=mock infection (media only), VACV-WR=Vaccinia-Western Reserve,
MPXV=Monkeypox-Zaire. Open Reading Frame (ORF), virus species, predicted timing of expression from VACV (Expr Time) [8] and protein function
are displayed. Poxvirus ORFs were spotted in duplicate on arrays, and resulting gene expression values relative to baseline (time 0) are displayed. The
intensity of the color reflects the magnitude of the change from baseline (264 fold to 64 fold change from baseline).
doi:10.1371/journal.pone.0002628.g002
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These poxvirus transcripts were detectable in both MPXV and
VACV infection as early as 2 hours post-infection, and reached levels
as high as 138-fold by 4–8 hours post infection (Figure 3). In addition
to the known early and immunomodulatory genes, 50 ORFs (from
MPXV or VACV) in the early expression cluster encode products
with unknown function.
The genes expressed at late timepoints (subset shown in Figure 4)
comprised 240 ORFs, including those encoding structural proteins
and major virion components (major virion core protein 4a
VACVWR129, A11L and 4b VACVWR122, MPXV A4L, IMV
membrane protein A28L, major component of IMV tubules
MPXV A28L, virion core DNA-binding MPXV C23R), and early
transcription factors that are packaged into the virion (large and
small subunits of viral early transcription factor VETF,
VACVWR126, VACVWR111, MPXV A8 and MPXV E6R,
and RAP94 required for transcription of early promoter templates
VACVWR102). 60 MPXV or VACV ORFs in this cluster encode
products with no known function.
As an alternative approach, we organized the transcriptome of
each virus in each cell type into a temporal map based on time of
transcription initiation, using Self Organizing Maps (SOMs)
[22,23] (10 nodes, 100,000 gene iterations). SOMs of the VACV
ORFs only during VACV WR infection and of the MPXV ORFs
only during MPXV infection (of primary human fibroblasts) are
shown in Figure 5. The overall temporal programs were similar
between the two viruses, with approximately half the viral genes
expressed at early timepoints (1–2 hours post infection), and half
expressed at late timepoints (4–24 hours post infection. The early
transcripts appeared to remain at steady state levels during the late
time period. In addition, transcripts representing almost all viral
genes appear to be detected at 24 hours post infection.
Viral species-specific transcripts
Several clusters of genes in the transcriptome map showed
expression by one virus, but not the other (e.g., MPXV-specific
cluster, Figure 6A). 16 MPXV ORFs and 12 VACV ORFs
showed strong expression by the corresponding virus, but little or
no expression by the other virus. 17 of the 28 genes detected as
virus species-specific (i.e. expression detected by MPXV spots but
not VACV spots or vice versa) were significantly differentially
expressed by VACV or MPXV, based on Significance Analysis of
Microarrays (SAM) [24] (two class paired timecourse, 1000
iterations, delta of 1.88, median false discovery rate=0), regardless
of host cell type (Figure 6B). We aligned the MPXV-ZAI and
VACV-WR genomes using Base-by-Base [25] and determined
that the array would detect ORFs as species specific with as little as
12.34% difference at the nucleotide level.
Mapping the virus transcriptome onto the physical map
of the viral genome
We aligned the expression data for all virus ORFs according to
genome position. The condensed overview is shown in Figure 7A
(top panel); a zoomed-in view of the left terminal region is shown
in the bottom panel. Overall, the transcriptional timing did not
appear to have a systematic relationship to position in the genome,
with the exception of early transcripts, which were disproportion-
ately distributed towards the termini of the genome, and late
transcripts which were concentrated in the central regions of the
genome (p,0.001 by t-test, Figure 7B). MPXV ORFs whose
predicted orthologs are fragmented in VACVV-WR showed
MPXV species-specific expression, as described above.
Further delineation of early and late viral gene
expression
In order to identify early and late expressed poxvirus genes
more accurately, we performed infection timecourses in primary
fibroblasts and in HeLa cells, according to the conditions used by
Baldick et al. [15]. In parallel, we mock infected cells, and infected
cells with killed MPXV, VACV-WR or MPXV-ZAI. Parallel
infections with VACV and MPXV were also performed in which
cycloheximide (CHX) was added to the media immediately after
viral adsorption, so as to block protein synthesis (including
synthesis of transcription factors necessary for intermediate and
late virus gene expression) and allow only expression of early
Figure 3. Detection of poxvirus gene transcripts-interferon modulators. Poxvirus genes whose products are known or predicted to
modulate interferon signaling. Timecourses are as follows: Mock=mock infection (media only), VACV-WR=Vaccinia-Western Reserve,
MPXV=Monkeypox-Zaire. The features of this display are similar to those in Figure 2.
doi:10.1371/journal.pone.0002628.g003
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with VACV or MPXV, then added hydroxyurea (HU) to the
media immediately after viral adsorption, so as to block viral DNA
replication and allow early viral proteins to accumulate; we then
washed out HU at 2 hours post-infection and added CHX to
allow transcription of intermediate but not late virus genes. The
resulting gene expression data are shown in Figure 8. CHX alone
and HU plus CHX efficiently blocked transcription of the viral
genes that we had previously classified as late-expressed genes, for
both MPXV and VACV (blue bar, 3
rd and 4
th triangle, versus 6
th–
9
th triangle, Figure 8). We developed a model to distinguish
between early (pre-genome replication) and late (post-genome
replication) transcription, based on expression value at 12 hours
post MPXV or VACV infection in untreated versus CHX or
CHX+HU-treated cells (Supplementary Table 3). This model
agreed with bioinformatics-based promoter predictions for vac-
cinia late genes (http://www.poxvirus.org/vaccinia_orthologs.
asp)for 65 out of 94 vaccinia genes with a predicted late promoter
(P,0.001 by exact binomial test). However it only agreed with
predicted promoters for 27 of 64 genes with predicted early
promoters, perhaps due to the number of genes with predicted
dual early and late promoters. This model allows for classification
of genes with no previous information as pre-DNA replication
(early) or post-DNA replication (late), and may aid in studies on
poxviral genes with previously unknown function.
Discussion
In order to examine the global temporal program of poxvirus
transcription during a synchronous infection, we developed a
specialized poxvirus-human microarray, containing probes repre-
senting every annotated ORF in the MPXV and VACV genomes.
We used this array to map the complete MPXV and VACV
transcriptomes with relatively dense temporal sampling. We
categorized all genes in the MPXV and VACV genomes
according to their transcriptional temporal profile (Figs 5 and 8).
These experiments allowed us to classify genes into the general
categories of ‘‘early’’ or ‘‘late’’ based on timing of hybridization
signal and weather or not viral DNA replication was required for
transcript detection. We observed the expected functional
categories of genes in each temporal class (i.e., genes involved in
viral transcription and DNA replication, as well as host immune
modulation were expressed early, and structural proteins, major
virion components and factors needed for early transcription in the
next cycle of replication were expressed late). However within each
class, there was variation as to the exact timing of transcription.
The standard vaccinia classification of genes as early, interme-
diate, or late is based on temporality of transcription initiation.
However this study is designed to detect the timing of the presence
of transcripts, as assessed by hybridization. The methods utilized
in this work are able to predict genes transcribed early or late in
Figure 4. Late viral gene expression during poxvirus infection. A subset of the complete monkeypox and vaccinia transcriptome
representative of the late transcripts. Timecourses are as follows: Mock=mock infection (media only), VACV-WR=Vaccinia-Western Reserve,
MPXV=Monkeypox-Zaire. The features of this display are similar to those in Figure 2.
doi:10.1371/journal.pone.0002628.g004
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only versus genes with an early and late promoter since early-only
transcripts may persist and be detected at late times. Some genes
have both an early and late promoter (as demonstrated
experimentally as well as predicted with bioinformatics methods).
These genes will have an expression pattern that behaves as an
early gene during the initial part of the life cycle, but as a late gene
during the latter part, potentially leading to partial, but not
complete blockage of transcript detection when viral DNA
replication is blocked. While we have not attempted to clearly
identify genes expressed both early and late in the replication
cycle, these genes would presumably comprise a subset of the early
expressed genes identified in this study.
We aligned the expression data for all virus ORFs according to
genome position. There did not appear to be a consistent
relationship between transcriptional timing and specific regions
of genome organization/structure, although there was a general
tendency for early transcripts to be located towards the termini
and late transcripts towards the central regions of the genome.
Many of the vaccinia genes have been temporally categorized
and the promoter sequences for early and late promoters have
been described [26–28]. Yet, 34% of predicted VACV-WR genes
do not have a reported expression phase, and 52 out of 218
VACV-WR genes are of unknown function [29,30]. In addition,
aside from bioinformatics predictions from the MPXV genome
sequence, nothing is known about the expression or timing of any
MPXV transcripts. With this complete transcriptome map of both
VACV and MPXV, many genes with previously unknown
function can now be classified as early, or late, thereby providing
clues to their function. Our poxvirus-human microarray was able
to detect the viral transcripts encoding the predicted MPXV
interferon-modulating genes. These results provide some of the
first evidence of specific MPXV immunomodulators being
expressed during live viral infection.
We noted that in the SOM analysis of the transcriptome, the
entire set of viral ORFs appeared to be transcribed by 24 hours
(Figure 5). While poxvirus early transcripts have a defined
termination signal, late transcripts have heterogeneous 39 ends
as the early termination signal is not recognized by the viral late
transcriptional apparatus. This ‘‘run-through transcription’’ pre-
sents the possibility of multi-ORF transcripts, where the transcript
of a late gene continues into the next downstream open reading
frame, due to the close proximity of poxvirus ORFs and relatively
small intergenic spacing. Such multi-ORF transcripts would
hybridize to array elements representing each of the included
genes. To address this issue, we used cycloheximide and
Figure 5. Self Organizing Maps-temporal transcription program. Self Organizing Maps (SOMs, 10 nodes, 100,000 gene iterations) of the gene
expression values relative to baseline (time 0) for VACV ORFs during VACV WR infection and MPXV ORFs during MPXV infection of primary human
fibroblasts. The intensity of the color reflects the magnitude of the change from baseline (264 fold to 64 fold change from baseline).
doi:10.1371/journal.pone.0002628.g005
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PLoS ONE | www.plosone.org 6 July 2008 | Volume 3 | Issue 7 | e2628Figure 6. Virus species-specific transcripts. (A) MPXV-specific transcript cluster (17 ORFs) was selected from overall unsupervised hierarchical
cluster of 407 MPXV and VACV genes (data not shown) and the resulting gene expression values relative to baseline (time 0) are shown. Mock=mock
infection (media only), VACV-WR=Vaccinia-Western Reserve, MPXV=Monkeypox-Zaire. The features of this display are similar to those in Figure 2. (B)
Significance Analysis of Microarrays (SAM) plot of 22 significant genes differentially expressed in VACV vs MPXV, (two class paired timecourse, 1000
iterations, delta of 1.88, median false discovery rate=0).
doi:10.1371/journal.pone.0002628.g006
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depended on viral DNA replication and protein synthesis and thus
more clearly segregate early and late classes of viral genes. The
resulting data clearly separated the transcriptional profiles into
early and late categories (Figure 8), and demonstrated that signal
intensities of early genes at later timepoints were not due to late
run-through transcription.
Microarrays developed for both Herpes Simplex Virus (HSV)-1
[17] and HSV-2 [18] have enabled transcriptional profiling of
each virus individually, as well as multi-species analysis of
herpesvirus transcriptomes. While a similar overall categorization
of HSV-1 and 2 kinetic classes was observed for orthologs,
comparative analysis demonstrated differential patterns of four
HSV transcripts which play a functional role in the nuclear
organization and localization of viral DNA [19] using cross
hybridization of HSV-2 transcripts on HSV-1 probes. For
poxviruses, we have observed a similar cross-hybridization
between VACV and MPXV array probes with the opposite viral
transcript (Figures 2, 4, and 6). We were able to identify 16 MPXV
ORFs and 12 VACV ORFs which are differentially expressed,
with 17 of the 28 virus-species specific genes statistically
significantly by Significance Analysis of Microarrays (False
discovery rate=0), regardless of host cell type. This microarray
was not designed to be diagnostic; by using whole-genome arrays
for each virus, probes were designed independent of degree of
cross-hybridization. However the species specificity profiling
analysis allows us to discriminate species-specific virus gene
expression with little as 12.34% difference at the nucleotide level.
Many of the species-specific genes are located in the highly
variable terminal genomic regions and in the inverted terminal
repeats. These may be ORFs which are significantly divergent at
the nucleotide level as to not cross-hybridize to the corresponding
Figure 7. Mapping of virus transcriptome to genome and distribution of promoters. (A) Top panel: Overview alignment of expression data
for all MPXV ORFs according to genome position, bottom panel: a zoomed-in view of the left terminal region, MPXV ZAI and VACV WR genome
alignment and homology of viral gene families. The MPXV ZAI and VACV WR genomes were then aligned using the viral orthologous cluster software
package (VOCS) [25,41], and the transcriptome expression data were mapped onto the alignment. Genes predicted to be expressed in MPXV [8] had
corresponding hybridization data (MPXV J1L, J2L, J3L, D1L, D2L and D3R and VACVWR 001, 003 and 009), while ORFs that are predicted to be
fragmented or missing in VACV (the ORFs corresponding with the MPXV J3L, D1L and D2L) were not detected with the MPXV probes. (B) Distribution
of genome position start sites by promoter type for MPXV-ZAI ORFs in fibroblasts.
doi:10.1371/journal.pone.0002628.g007
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are not expressed at all in the corresponding viral species. These
differentially expressed ORFs include transcripts for MPXV
proteins which have not previously been characterized as well as
ORFs which are critical to modulation of host defenses (viral
suppressors of Toll-like receptor signaling, secreted TNFa and
IFNa/b decoy receptor, and IL-18 binding protein). These
differentially expressed genes may be critical factors in elucidating
pathogenesis differences between MPXV and VACV.
During review of our paper, a study was published examining
VACV transcriptional responses in HeLa cells using short-
oligonucleotide microarray profiling [31]. Overall, transcription
patters were observed to be similar between the short-oligonuceo-
tide and cDNA microarray platforms. Our analysis extends these
results to MPXV, as well as primary cell culture, which may be a
more relevant biological system. This study represents the first
analysis of the complete virus transcriptome for both VACV and
MPXV. This map of the transcriptional timing of all viral genes
can be used to interrogate functions of unknown viral genes and
dissect the intricate dialogue between virus and host.
Materials and Methods
Cells, and culture conditions
In order to obtain primary human monocytes, elutriated
monocytes were collected from two different healthy donors
through the NIH Blood Bank and also from Clonetics (San Diego,
CA). The cells were isolated according to conventional procedures
and cultured in 6- or 12-well plates containing RPMI 1640
medium and 10% heat-inactivated fetal calf serum (FCS,
Invitrogen, Carlsbad, CA). The use of primary human cells for
research purposes was approved by the Institutional Review Board
Figure 8. Block of late virus transcription with cycloheximide and/or hydroxyurea. Hierarchical clustering of 814 poxvirus elements. The
level of expression of each gene, in each sample, relative to the mean expression level of that gene across all of the samples was determined. The
intensity of the color reflects the magnitude of the change relative to the rest of the samples (264 fold to 64 fold change). Mock=mock infection
(media only); c-MPXV=killed (gamma-irradiated) Monkeypox-Zaire; VACV-WR=Vaccinia-Western Reserve; MPXV=Monkeypox-Zaire; CHX=cyclo-
heximide; CHX+VACV=VACV infected, CHX added immediately post-infection; CHX+MPXV=MPXV infected, CHX added immediately post-infection;
HU+VACV=VACV infected, hydroxyurea (HU) added immediately post-infection then washed out at 2 hours post-infection and CHX added;
HU+MPXV=MPXV infected, HU added immediately post-infection then washed out at 2 hours post-infection and CHX added.
doi:10.1371/journal.pone.0002628.g008
Poxvirus Gene Expression
PLoS ONE | www.plosone.org 9 July 2008 | Volume 3 | Issue 7 | e2628of Stanford University. Monocytes were cultured for 2–6 days to
allow differentiation into monocyte-like cells. Primary human
dermal fibroblasts were either derived from skin samples obtained
at autopsy, after removal of keratinocytes and endothelial cells, as
described [32] (S100), or obtained from Clonetics (NHDF). S100
primary fibroblasts were cultured in Dulbecco’s Modified Eagle’s
Medium (DMEM) with 10% FCS, glutamine, and 100 units
penicillin-streptomycin (Invitrogen, Carlsbad, CA); NHDF prima-
ry fibroblasts were cultured in fibroblast growth medum 2
(Clonetics, San Diego, CA) supplemented with 2% FCS human
fibroblast growth factor-B, insulin, and gentamicin/amphotericin-
B, according to the manufacturer’s directions. HeLa cells (ATCC,
Manassas, VA) were cultured in DMEM with 10% FCS,
glutamine, and 100 units penicillin-streptomycin.
Viral infection
Cells were plated in 6- or 12-well plates and rested for 24 hours.
Cells were infected at a multiplicity of infection (MOI) of 10 with
either Vaccinia New York Board of Health (Wyeth, Dryvax)
(VACV-NYCBH), Vaccinia Western Reserve (VACV-WR, [33],
kindly provided by B. Moss), or Monkeypox-Zaire (MPXV-ZAI,
CDC isolate V79-I-005 [7]). Control live virus infections were
performed at an MOI of 10 with Ebola-Zaire (EBOV-ZAI) [34].
Control killed virus infections were performed with gamma-
irradiated MPXV-ZAI. For preparation of killed MPXV, the stock
of MPXV-ZAI was split into equal aliquots, half was used for the
live virus infection, and half was subjected to 1610
6 rads of
gamma-irradiation from a
60Cobalt source. Mock infections were
performed using culture medium free of any viruses. All viral
infections were performed at U.S. Army Medical Research
Institute of Infectious Diseases, Frederick, MD at Biosafety Level
3 (MPXV) or 4 (EBOV-ZAI) in accordance with NIH/CDC
Biosafety in Microbiological and Biomedical Laboratories guide-
lines, as well as in accordance with CDC Select Agent regulations.
After incubation of virus with host cells for 1 hour at 37uC with
periodic rocking, the virus-containing medium (or mock medium)
was removed, cells were washed twice with phosphate-buffered
saline, and replaced with fresh culture medium. Cells were then
incubated for various times at 37uC. Samples were collected in
duplicate or triplicate immediately prior to infection (‘‘time zero’’)
for all timecourses in order to ensure a robust baseline for data
analysis. The range of timepoints was chosen to cover to the first
24 hours post-infection, so as to include the expected periods of
vaccinia early stage (1–2 hr [15]), intermediate stage (100 min–
2 hr [15]), and late stage (140 min–24 hr [35]) transcription.
In some experiments, exogenous compounds were added to the
media after infection to elicit specific responses. To examine the
effects of blocking late virus transcription, HeLa cells were either
mock infected (as described above), or infected with MPXV-ZAI
at an MOI of 10. After unadsorbed virus was removed, fresh
media containing 100 ug/mL (final concentration) of cyclohexi-
mide (CHX, Sigma, St. Louis, MO) was added to the mock- or
MPXV-infected cells. In some experiments, hydroxyurea (HU,
Sigma, St. Louis, MO) was added at a final concentration of
10 mM, instead of cycloheximide. HU was washed out at 2 hrs
post infection, then fresh media containing 100 ug/mL final
concentration of CHX was added and samples were collected at
various timepoints. Cell cultures were visualized using phase-
contrast microscopy at each timepoint and images captured.
Plaque assays
Cell supernatants were collected for virus titration and soluble
factor assays at the same times that RNA was harvested; the
supernatant was frozen at 280uC until subsequent analysis.
Supernatants were diluted from 10
21 to 10
26 in 200 uL of MEM.
Diluted supernatants were added in duplicate to confluent
monolayer cultures of Vero E6 cells and incubated for 1 hour at
37uC with periodic rocking. Supernatants were removed and a
0.5% agarose solution with 2% EBME, HEPES and 10% FBS was
overlayed. Cells were incubated at 37uC for 4–5 days, followed by
removal of the agarose overlay. Plaques were stained with 2 mL of
crystal violet solution and counted.
RNA preparation for microarray analysis
Total RNA from cells was harvested at each timepoint by
removal of media and addition of 1 mL of TriPure (Roche
Applied Science, Indianapolis, IN) directly to the infected/treated
cells in the culture well. RNA was extracted using TriPure reagent
and linearly amplified (Ambion MessageAmp, Ambion, Austin,
TX) according to the manufacturer’s instructions.
DNA microarrays and hybridization
We used custom-designed DNA microarrays containing ele-
ments for both human and poxvirus genes. These microarrays
contained 37,632 elements that represent approximately 18,000
unique human genes ([36,37]). We designed primers for all 190
predicted open reading frames (ORFs) in the MPXV-ZAI genome
(Genbank accession AF380138) and all 217 predicted ORFs in the
vaccinia-WR genome (Genbank accession AY243312) [21]. Using
purified MPZ-ZAI and VACV-WR virus genomic DNA as a
template, PCR reactions were performed and PCR products were
purified (according to the methods described at (http://www.
microarray.org/doc/protocol/PCRprotocol.rtf) and each product
was transferred twice to a 384-well plate (http://www.microarray.
org/doc/protocol/96_to_384_well_transfer.rtf). Therefore, each
PCR product representing a MPXV or VACV ORF was
duplicated in the 384-well plate and was represented twice on
the microarray. These poxvirus PCR products ranged in size from
100 to 348 bp (179 mean), see Supplementary Tables 1 and 2 for
primer sequences and amplicons.
Fluorescently-labeled cDNA prepared from amplified RNA was
hybridized to the array in a two color comparative format [36,38],
with the experimental samples labeled with one fluorophore (Cy-5)
and a reference pool of mRNA labeled with a second fluorophore
(Cy-3). The reference pool (Universal Human Reference,
Stratagene Inc.) and a mix of poxvirus transcripts from all
timepoints provided an internal standard to enable reliable
comparison of relative transcript levels in multiple samples
[36,37,39]. Fluorescent images of hybridized microarrays were
acquired using the GenePix 4000B and GenePix 4200AL
microarray scanners (Axon Instruments, Union City, CA).
The data discussed in this publication have been deposited in
NCBIs Gene Expression Omnibus (GEO, http://www.ncbi.nlm.
nih.gov/geo/) and are accessible through GEO Series accession
number GSE11234. In addition array image files, raw and filtered
data are available through the Stanford Microarray database
http://smd-www.stanford.edu//
Data Filtering and Analysis
Microarray images were analyzed with GenePix Pro 5.0
(http://www.axon.com/GN_GenePixSoftware.html, Axon In-
struments, Union City, CA) and Spot Reader (Niles Scientific,
Portola Valley, CA). Single spots or areas of the array with obvious
blemishes were flagged and excluded from subsequent analyses.
Fluorescence ratios (along with numerous quality control param-
eters; see GenePix Pro and SpotReader manuals) were stored in a
custom database [40]. Clones that consistently behaved poorly
(e.g., flagged data in .20% of arrays) were identified and excluded
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dently for each array by applying a single scaling factor to all
fluorescent ratios from each; this scaling factor was computed so
that the median fluorescence ratio of well-measured spots on each
array was 1.0. All non-flagged array elements for which the
fluorescent intensity in each channel was greater than 2.5 times the
local background and for which the regression correlation of the
pixels in each channel was at least 0.6 on at least 80% of arrays,
were considered well-measured. Data were expressed as the log2
ratio of fluorescence intensities of the sample and the reference, for
each element on the array [36,38]. The data from multiple
independent Time 0 samples were averaged to provide a robust
baseline. The timecourse data were then zero-transformed (the
value for each element at day 0 for a given time course was
subtracted from the rest of the values for that element within that
time course). The subset of elements that varied from the baseline
by at least 3 fold in at least 3 samples was selected for further
analysis. The data were hierarchically clustered using the Cluster
program [23] and displayed using TreeView (http://rana.lbl.gov/
EisenSoftware.htm).
Classification of early vs. late genes from expression
profiles
Data from 12-hours post-VACV or MPXV infection were
normalized by scaling the mean of all probes to the global mean of
each of these hybridizations. Probes from hybridizations of cells
12 hours post VACV or MPXV infection treated with CHX or
HU+CHX were also scaled similarly across each group. To
discriminate between early and late genes, a ‘‘lateness score’’ was
calculated by subtracting the mean expression value of probes for
cells infected with VACV or MPXV and treated by CHX or
HU+CHX (n=4) from that of cells infected with VACV or
MPXV only (n=2) and dividing by the standard deviation of the
treated cells. Genes were ranked by this lateness score, with the top
half (exhibiting the most reproducible effect of CHX or HU+CHX
treatment; lateness score .1.6) being assigned a ‘‘late’’ mode of
expression regulation and the remaining genes assigned an ‘‘early’’
mode (Supplementary Table 3).
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